cerrar
Tagged with Investment,

Time to Build More Windmills: Reflections from the ChinaBio…
After four years away, Brendan Shaw recently returned to China to attend the ChinaBio Innovation and Investment Conference in Suzhou. Although…

China’s Greater Bay Area: Living up to the Hype?
A decade on from its launch, the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) initiative has made some significant wins but remains some way from…

Hong Kong: Becoming a Biotech Funding Hub
2018 marked a significant milestone in Hong Kong’s journey towards creating a vibrant biotech market for investors which allows Asian innovation to…

Fadela Benjelloun – Executive Director, LEMM, Morocco
Fadela Benjelloun, executive director of LEMM, the association of multinational pharma companies in Morocco, looks back on the evolution of the…

JLABS’ Global Head On Open Innovation & Writing…
Biotech and life sciences companies have a habit of clustering together, creating shared ecosystems to drive innovation. For going on 12 years Johnson…

Albert Wong – CEO, Hong Kong Science and Technology Parks…
Albert Wong of the Hong Kong Science and Technology Parks Corporation (HKSTP) outlines how Hong Kong has developed as an innovation hub, building on…

Noura Al Ghaithi – Undersecretary of the Department of…
Speaking exclusively to PharmaBoardroom, H.E. Dr Noura Al Ghaithi, Undersecretary of the Department of Health Abu Dhabi outlines Abu Dhabi's rapid…

Christina Bao – Co-Head of Sales and Marketing, Hong Kong…
Since first allowing pre-revenue biotechs to list in 2018, the Hong Kong stock exchange has welcomed 59 such companies and is now a leading vehicle…

Xia Jiasheng – CEO, Guangdong Medical Valley
First set up in 2014, the Guangdong Medical Valley is an investment incubation platform in southern China focusing on the biomedical and medical…

EU Pharma Reform: A Medicine with Serious Side Effects 
Rainer Westermann, chairman of the Life Sciences Acceleration Alliance e.V. (LSAA), which lobbies on behalf of European venture capitalists in the…

Hong Kong: Hopes for the Beginning of Asian Biotech’s New Era
Looking ahead to the Hong Kong International Biotechnology Convention (BIOHK2023) taking place between 13-16 September 2023 at the Hong Kong…

Cell & Gene Therapy Approvals & Sector Snapshot 2023
The Alliance for Regenerative Medicine (ARM) brands itself as the leading international advocacy organization championing the benefits of engineered…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here